John V. Segas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
John V. Segas has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Alexandra D. Kontrogiannis
Department of Otolaryngology, University of Athens School of Medicine, Athens, Greece
1 shared publication- Alexandros Georgolios
Department of Otolaryngology-Head and Neck Surgery, University of Ioannina, Ioannina, GRC
1 shared publication Andreas C. Lazaris
1 shared publicationAngeliki H. Boussiotou
Department of Pathology, Hippokration General Hospital, Athens, Greece
1 shared publicationAntonios M. Tzagkaroulakis
1 shared publicationEfstratios S. Patsouris
1 shared publication
Latest Publications
- Open Access
- 11 August 2009
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 7 (1) , 65
Supracricoid hemilaryngopharyngectomy for selected pyriform sinus carcinoma patients – a retrospective chart review
The aim of this study is to assess the functional and oncologic results of supracricoid hemilaryngopharyngectomy and report our experience in the technique, local control and overall survival rates.
- 11 August 2009
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 7 (1) , 65
Open AccessSupracricoid hemilaryngopharyngectomy for selected pyriform sinus carcinoma patients – a retrospective chart review
The aim of this study is to assess the functional and oncologic results of supracricoid hemilaryngopharyngectomy and report our experience in the technique, local control and overall survival rates.
- 1 December 2005
- Published by S. Karger AG in ORL
- Vol. 67 (6) , 319-325
Cyclin D1 Protein Tissue Detection in Laryngeal Cancer
Cyclin D1 (CCND1) is a set of periodic regulatory proteins that is believed to govern cell cycle transit from G1 into S phase. Overexpression of CCND1 leads to abnormal cellular proliferation which underlies processes of tumorigenesis; CCND1 can thus function as a cooperative oncogene in cell transformation. In the present study we investigate the immunohistochemical expression of CCND1 in a well-documented series of 58 laryngeal squamous cell carcinomas (LSCC) and search for statistical associations between CCND1 index and various clinicopathological parameters including several immunomarkers’ expression as well as patients’ disease-free survival. Tissue sections from archival paraffin blocks were stained using the avidin-biotin-peroxidase complex method; the H-295 rabbit polyclonal antibody was applied at dilution of 1:150. The percentage of CCND1 immunoreactive tumor cells for each tumor was counted by an image analysis system. CCND1 staining was confined to cell nuclei and, in the examined samples, ranged from undetectable (i.e. 0% of tumor cells, n = 6) to the majority of tumor cells (i.e. 89% of tumor cells) with mean value: 15.73%. In tumor adjacent, non invasive lesions, strong CCND1 staining was noticed in areas with cellular atypia. In cases with nodal metastases, no change in CCND1 expression in the nodal metastases compared with the primary tumors was observed. p53 protein accumulation in malignant cells was positively linked with CCND1 index (Mann-Whitney U: 205.5, p = 0.034). CCND1 expression appears to be an early event in processes of tumorigenesis and tumor progression in some LSCC. Apart from p53 protein accumulation, CCND1 immunohistochemical expression does not seem to correlate with nodal metastasis, disease recurrence or any other clinicopathological prognostic indicator.
- 1 December 2005
- Published by S. Karger AG in ORL
- Vol. 67 (6) , 319-325
Cyclin D1 Protein Tissue Detection in Laryngeal Cancer
Cyclin D1 (CCND1) is a set of periodic regulatory proteins that is believed to govern cell cycle transit from G1 into S phase. Overexpression of CCND1 leads to abnormal cellular proliferation which underlies processes of tumorigenesis; CCND1 can thus function as a cooperative oncogene in cell transformation. In the present study we investigate the immunohistochemical expression of CCND1 in a well-documented series of 58 laryngeal squamous cell carcinomas (LSCC) and search for statistical associations between CCND1 index and various clinicopathological parameters including several immunomarkers’ expression as well as patients’ disease-free survival. Tissue sections from archival paraffin blocks were stained using the avidin-biotin-peroxidase complex method; the H-295 rabbit polyclonal antibody was applied at dilution of 1:150. The percentage of CCND1 immunoreactive tumor cells for each tumor was counted by an image analysis system. CCND1 staining was confined to cell nuclei and, in the examined samples, ranged from undetectable (i.e. 0% of tumor cells, n = 6) to the majority of tumor cells (i.e. 89% of tumor cells) with mean value: 15.73%. In tumor adjacent, non invasive lesions, strong CCND1 staining was noticed in areas with cellular atypia. In cases with nodal metastases, no change in CCND1 expression in the nodal metastases compared with the primary tumors was observed. p53 protein accumulation in malignant cells was positively linked with CCND1 index (Mann-Whitney U: 205.5, p = 0.034). CCND1 expression appears to be an early event in processes of tumorigenesis and tumor progression in some LSCC. Apart from p53 protein accumulation, CCND1 immunohistochemical expression does not seem to correlate with nodal metastasis, disease recurrence or any other clinicopathological prognostic indicator.
- Open Access
- 1 July 2001
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 80 (7) , 468-470
A Neurilemmoma of the Parotid Gland: Report of a Case
Benign primary tumors of the facial nerve are frequently misdiagnosed because of the variety of their clinical manifestations. Much attention has been paid to neurilemmomas in the recent otolaryngologic literature, but far less has been focused on intraparotid facial nerve neurilemmomas. In this article, we describe a new case of this truly rare tumor, and we review its diagnosis, pathology, and treatment.
- 1 July 2001
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 80 (7) , 468-470
Open AccessA Neurilemmoma of the Parotid Gland: Report of a Case
Benign primary tumors of the facial nerve are frequently misdiagnosed because of the variety of their clinical manifestations. Much attention has been paid to neurilemmomas in the recent otolaryngologic literature, but far less has been focused on intraparotid facial nerve neurilemmomas. In this article, we describe a new case of this truly rare tumor, and we review its diagnosis, pathology, and treatment.